GlassScriptPhysician profile
Jeffrey A Steiner
NPI 1356343859
$1,754.12
in general payments reported to CMS, 2019-2025
18 companies · $1,004 in 2025
The $1,004 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $109 · 2021: $191 · 2022: $142 · 2023: $87.47 · 2024: $69.26 · 2025: $1,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $547.27 | 2019-2025 | Viberzi, Linzess |
| Janssen Biotech, INC. | $358.88 | 2022-2025 | Tremfya, Stelara |
| Ardelyx, INC. | $172.49 | 2025 | Ibsrela |
| Boston Scientific Corporation | $104.08 | 2019-2025 | Watchman Flx |
| Aimmune Therapeutics, INC. | $83.92 | 2025 | Zenpep, Vowst |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.20 | 2019-2025 | Xifaxan |
| Redhill Biopharma INC. | $57.37 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.22 | 2025 | Entyvio, Gattex |
| Madrigal Pharmaceuticals | $49.75 | 2025 | Rezdiffra |
| Gilead Sciences, INC. | $46.17 | 2019-2022 | |
| Exact Sciences Corporation | $42.31 | 2023-2024 | Cologuard Collection Kit |
| Intercept Pharmaceuticals, INC. | $34.66 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $30.86 | 2024 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $26.60 | 2025 | Dupixent |
| Pfizer INC. | $24.18 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $17.75 | 2025 | |
| Ironwood Pharmaceuticals, INC | $17.34 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Steiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.